These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3593628)

  • 1. Ibopamine (SK&F 100168) pharmacokinetics in relation to the timing of meals.
    Scott SC; Locke-Haydon J; Pready NS; Buller NP; Cregeen RJ
    Br J Clin Pharmacol; 1987 May; 23(5):585-7. PubMed ID: 3593628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ibopamine kinetics after single and multiple dosing in patients with congestive heart failure.
    Azzollini F; De Caro L; Longo A; Pelosi G; Rolandi E; Ventresca GP; Lodola E
    Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):544-51. PubMed ID: 3243658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the bioequivalence of three oral formulations of ibopamine in healthy volunteers.
    Douchamps J; Juvent M; Vanschoubroek K; Seth A; Deger F; Derenne F; Herchuelz A
    Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):482-6. PubMed ID: 3069751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in dogs.
    Pocchiari F; Pataccini R; Castelnovo P; Longo A; Paro M; Casagrande C
    Arzneimittelforschung; 1986 Feb; 36(2A):341-4. PubMed ID: 3707646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of ibopamine on different diseases and conditions.
    Ventresca GP; Lodola E
    Arzneimittelforschung; 1988 Aug; 38(8):1175-80. PubMed ID: 2904270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in rats.
    Pocchiari F; Pataccini R; Castelnovo P; Longo A; Casagrande C
    Arzneimittelforschung; 1986 Feb; 36(2A):334-40. PubMed ID: 3707645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibopamine kinetics after a single oral dose in patients with congestive heart failure.
    Azzollini F; Cattò G; Iacuitti G; Pelosi G; Picca M; Pocchiari F; Pataccini R; Castelnovo P; Longo A; Ventresca GP
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):105-12. PubMed ID: 3410586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
    De Vita C; Triulzi E; Devizzi S; Colombo G; Palvarini M; Pocchiari F; Pataccini R
    Arzneimittelforschung; 1986 Feb; 36(2A):349-54. PubMed ID: 3707648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibopamine kinetics after a single oral dose in healthy volunteers.
    Lodola E; Borgia M; Longo A; Pocchiari F; Pataccini R; Sher D
    Arzneimittelforschung; 1986 Feb; 36(2A):345-8. PubMed ID: 3707647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ibopamine in patients with renal impairment.
    Salvadeo A; Villa G; Bovio G; Pocchiari F; Pataccini R; Longo A; Ventresca GP
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):98-104. PubMed ID: 3410592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of epinine and its metabolites in man after oral administration of its pro-drug ibopamine using high-performance liquid chromatography with electrochemical detection.
    Gifford R; Randolph WC; Heineman FC; Ziemniak JA
    J Chromatogr; 1986 Aug; 381(1):83-93. PubMed ID: 3771727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dopamine, ibopamine, and epinine on alpha- and beta-adrenoceptors in canine pulmonary circulation.
    Shebuski RJ; Smith JM; Ruffolo R
    Fundam Clin Pharmacol; 1989; 3(3):211-21. PubMed ID: 2548941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the alpha adrenoceptor activity of dopamine, ibopamine and epinine in the pulmonary circulation of the dog.
    Shebuski RJ; Fujita T; Smith JM; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Apr; 241(1):6-12. PubMed ID: 3033210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
    Kopia GA; Ohlstein EH; Ruffolo RR
    J Pharmacol Exp Ther; 1988 Aug; 246(2):434-40. PubMed ID: 3404441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the alpha and beta adrenoceptor-mediated activities of the novel, orally active inotropic agent, ibopamine, in the cardiovascular system of the pithed rat: comparison with epinine and dopamine.
    Nichols AJ; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):455-63. PubMed ID: 3039117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
    Dei Cas L; Metra M; Nodari S; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of single oral doses of ibopamine, quinidine and their combination in normal man.
    de Mey C; Enterling D; Brendel E; Wesche H
    Eur J Clin Pharmacol; 1988; 34(4):415-8. PubMed ID: 3402527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary vascular activity of the novel inotropic pro-drug ibopamine and the de-esterified active form epinine.
    Ohlstein EH; Kopia GA; Ruffolo RR
    Arzneimittelforschung; 1988 Dec; 38(12):1790-2. PubMed ID: 3245851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic interactions between single oral doses of ibopamine and food in normal man.
    de Mey C; Enterling D; Meineke I
    Arzneimittelforschung; 1989 Sep; 39(9):1138-43. PubMed ID: 2590265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.